z-logo
Premium
Active surveillance of patients who have melanoma with a positive sentinel node in an era of effective adjuvant therapy: Early lessons learned … and still learning
Author(s) -
Gershenwald Jeffrey E.
Publication year - 2021
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.33484
Subject(s) - medicine , sentinel node , adjuvant therapy , melanoma , randomized controlled trial , adjuvant , surgery , oncology , cancer , chemotherapy , cancer research , breast cancer
The analysis by Broman and colleagues in this issue contributes to a still rapidly developing evidence base of patients with melanoma and a positive sentinel node who are followed with active surveillance. It reveals substantial adoption of randomized clinical trial findings that support active surveillance for these patients and, with limited follow‐up, suggests that loss of regional basin control is a very uncommon event in this era of effective adjuvant therapy.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here